Delivery Order 36F79718D0509-36C26025F0139
Award Date
2/10/25
Potential Completion Date
9/30/25
Potential Value
$176K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Merck Sharp & Dohme LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Belzutifan (Welireg) 40 mg, a pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer and supplier to the federal government. The contract is a Delivery Order under Merck's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. It has a firm fixed price of $19,964.86 and a completion date of...
This is a delivery order contract awarded by the Veterans Integrated Service Network 20 (VISN 20), a civilian agency within the U.S. Department of Veterans Affairs, to Merck Sharp & Dohme LLC, doing business as Merck. The contract is for the pharmaceutical product Welireg (belzutifan), which is used for cancer treatment. The award has a ceiling value of $262,530.15 and is a firm fixed-price contract. The contract is not designated as a set-aside. Merck is a major pharmaceutical...
This is a delivery order awarded by the Veterans Integrated Service Network 20 (VISN 20), part of the U.S. Department of Veterans Affairs (VA), to Merck Sharp & Dohme LLC (Merck), a major pharmaceutical manufacturer. The contract is for the supply of Welireg (belzutifan), a cancer treatment drug, with a ceiling value of $259,543.18 and a period of performance ending on September 30, 2025. The contract is not set aside and is issued under Merck's Federal Supply Schedule (FSS) contract for...
The Department of Veterans Affairs Veterans Health Administration awarded a $19,964.86 firm-fixed-price delivery order contract to Merck Sharp & Dohme LLC, doing business as Merck, for the pharmaceutical drug Welireg (Belzutifan) 40mg tablets. This award is under Merck's existing General Services Administration Federal Supply Schedule (FSS-61-IB) contract for pharmaceuticals and drugs. The contract has a completion date of June 7, 2024. Merck is a major pharmaceutical manufacturer that has...
This federal contract award was made by the Veterans Integrated Service Network 20 (VISN 20) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract is for the delivery of the cancer drug Welireg (belzutifan) and is a Firm Fixed Price Delivery Order under Merck's Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract. The contract has a ceiling value of $59,894.58 and a period of performance ending on January 31, 2025. The...
The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract to Merck Sharp & Dohme LLC, doing business as Merck, for the supply of the cancer drug Welireg (belzutifan). The $239,578.32 contract was awarded on February 1, 2025, with a completion date of January 31, 2026. This award is a part of Merck's larger Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs. Merck, a major pharmaceutical manufacturer, has an extensive portfolio of...
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The order is for the drug Welireg (belzutifan) 40mg tablets, National Drug Code 00006-5331-01. The award has a ceiling value of $19,964.86 and an ultimate completion date of July 10, 2024. This delivery order falls under Merck's prime contract on the...
This is a Delivery Order contract awarded by the Veterans Integrated Service Network 5 (VISN 5), a defense agency, to Merck Sharp & Dohme LLC (doing business as Merck), a major pharmaceutical manufacturer. The contract is for the delivery of the drug BELZUTIFAN (WELIREG) 40 MG, which is used for cancer treatment. The contract has a ceiling value of $19,964.86 and is a Firm Fixed Price contract type. The contract is not set aside for any specific business category. Merck is a large for-profit...
This is a delivery order issued under a Federal Supply Schedule (FSS) contract with Merck Sharp & Dohme LLC, doing business as Merck, for the pharmaceutical product Belzutifan (Welireg) 40 mg. The contract was awarded by the Department of Veterans Affairs, Veterans Integrated Service Network 5, with a total ceiling value of $22,051.39. The delivery order has a firm fixed price pricing type and has an ultimate completion date of April 10, 2025. Merck, a major pharmaceutical manufacturer,...
This federal contract award, valued at $78,114.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of KEYTRUDA 100 MG/4 ML VIAL 4ML, a critical pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...